Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Symptom severity | |||||
Systematic review |
164 people with first-episode psychosis, who are antipsychotic naive Data from 1 RCT |
Mean difference in change from baseline in Scale for the Assessment of Negative Symptoms (SANS) total score
12 weeks
with chlorpromazine (600 mg/day) with clozapine (400 mg/day) Absolute results not reported |
P = 0.01 |
Effect size not calculated | clozapine |
Systematic review |
164 people with first-episode psychosis, who are antipsychotic naive Data from 1 RCT |
Mean difference in change from baseline in SANS total score
52 weeks
with chlorpromazine (600 mg/day) with clozapine (400 mg/day) Absolute results not reported |
P = 0.40 |
Not significant | |
Systematic review |
164 people with first-episode psychosis, who are antipsychotic naive Data from 1 RCT |
Mean difference in change from baseline in Clinical Global Impression scale Severity (CGI-S) score
12 weeks
with chlorpromazine (600 mg/day) with clozapine (400 mg/day) Absolute results not reported |
P = 0.13 |
Not significant | |
Systematic review |
164 people with first-episode psychosis, who are antipsychotic naive Data from 1 RCT |
Mean difference in change from baseline in CGI-S score
52 weeks
with chlorpromazine (600 mg/day) with clozapine (400 mg/day) Absolute results not reported |
P = 0.36 |
Not significant |